Developmental Therapeutics

The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is a premiere destination for accessing Phase I clinical trials aimed at defeating cancer.

Why Siteman?

Siteman specializes in first-in-human studies (Phase I clinical trials) that are typically very small (20-50 patients). We also conduct a great deal of investigator-initiated trials (IITs), where one of our doctors works with a drug company to initiate their own protocol.

Scientists and physicians affiliated with Siteman hold more than $145 million annually in basic and clinical oncology research grants. The results of basic laboratory research are rapidly incorporated into treatment advances, which is enhanced by patient access to more than 500 therapeutic clinical trials, including many collaborative efforts with other leading cancer centers throughout the country.

Washington University Physicians at Siteman are repeatedly recognized as some of the best in the world. They provide patient care that is thorough and a level of attentiveness that is unmatched.

Request an Appointment Today

Are you interested in talking more about a Phase I trial for you or a patient of yours? Please call or fill out our web form to begin the process.